Drag a card by its title · ⚙ to size, swap or remove

The company

LeonaBio, Inc.

LONA · Nasdaq

Health CareBiotechnologyNot moving yet

LONA stood above a rising 150-day average in 38 of the last 52 weekly readings, and has been out of that trend for the last 9 weeks. It is 36.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 9
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $199K
Officials’ trades on record: 0
Institutions holding: 43 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 38 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months10

Buyers · sellers0 · 5

Who	Did	Shares	Traded
Mark James LittonPRESIDENT and CEO	sold	5,156at $5.37	4 Mar 2026filed 5 Mar 2026
Martin Javier SanCHIEF MEDICAL OFFICER	sold	1,720at $5.37	4 Mar 2026filed 5 Mar 2026
Kevin ChurchCHIEF SCIENTIFIC OFFICER	sold	1,359at $5.37	4 Mar 2026filed 5 Mar 2026
Mark WorthingtonGENERAL COUNSEL and CCO	sold	1,328at $5.37	4 Mar 2026filed 5 Mar 2026
Robert RenningerCHIEF FINANCIAL OFFICER	sold	906at $5.37	4 Mar 2026filed 5 Mar 2026
Mark James LittonPresident and CEO	sold	2,586at $6.88	2 Jan 2026filed 5 Jan 2026
Martin Javier SanCHIEF MEDICAL OFFICER	sold	1,644at $6.88	2 Jan 2026filed 5 Jan 2026
Kevin ChurchCHIEF SCIENTIFIC OFFICER	sold	876at $6.88	2 Jan 2026filed 5 Jan 2026
Mark WorthingtonGeneral Counsel and CCO	sold	876at $6.88	2 Jan 2026filed 5 Jan 2026
Robert RenningerChief Financial Officer	sold	297at $6.88	2 Jan 2026filed 5 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders43+6 on the quarter

New · exited9 · 3

Reported value$66.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
PERCEPTIVE ADVISORS LLCunchanged · filed 14 Aug 2026	1,859,322$17.1M	00.0%
ADAR1 Capital Management, LLCadded · filed 14 Aug 2026	777,100$7.1M	+49,619+6.8%
ACORN CAPITAL ADVISORS, LLCunchanged · filed 14 Aug 2026	634,539$5.8M	00.0%
NEA Management Company, LLCunchanged · filed 14 Aug 2026	464,398$4.3M	00.0%
Commodore Capital LPunchanged · filed 14 Aug 2026	464,398$4.3M	00.0%
TCG Crossover Management, LLCunchanged · filed 14 Aug 2026	464,398$4.3M	00.0%
Spruce Street Capital LPunchanged · filed 13 Aug 2026	393,701$3.6M	00.0%
Kalehua Capital Management LLCunchanged · filed 14 Aug 2026	393,701$3.6M	00.0%
Blackstone Inc.new · filed 14 Aug 2026	324,638$3.0M	+324,638
ADAGE CAPITAL PARTNERS GP, L.L.C.new · filed 14 Aug 2026	300,000$2.8M	+300,000